FRM
SYRS

Fox Run Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Fox Run Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,283
Closed -$70K – 654
2021
Q2 		$70K Buy
+1,283
New +$70K 0.06% 326